miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
miRNA27a Is a Biomarker for Predicting Chemosensitivity and Prognosis in Metastatic or Recurrent Gastric Cancer
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume 115, Issue 3, Pages 549-556
Publisher
Wiley
Online
2013-10-12
DOI
10.1002/jcb.24689
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy†
- (2013) Z.-Q. Jiang et al. ANNALS OF ONCOLOGY
- Muscle-specific MicroRNA1 (miR1) Targets Heat Shock Protein 70 (HSP70) during Dexamethasone-mediated Atrophy
- (2013) Himani Kukreti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- c-MYC-regulatedmiR-23a/24-2/27aCluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2
- (2013) Xiaoni Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02
- (2012) Yoon Hee Choi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer
- (2012) Kun Liu et al. World Journal of Surgical Oncology
- Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells
- (2011) Xiaohong Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer
- (2011) Mi Ran Jung et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Significance of miR-181b and miR-21 in Gastric Cancer Patients Treated with S-1/Oxaliplatin or Doxifluridine/Oxaliplatin
- (2011) Jingting Jiang et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis
- (2010) Rui Liu et al. EUROPEAN JOURNAL OF CANCER
- Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
- (2009) Hongwei Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
- (2009) E K O Ng et al. GUT
- Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells
- (2008) Hua Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
- (2008) Qing Ji et al. BMC CANCER
- Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group
- (2008) J G Kim et al. BRITISH JOURNAL OF CANCER
- MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin
- (2008) Tao Liu et al. CANCER LETTERS
- MicroRNA Microarray Identifies Let-7i as a Novel Biomarker and Therapeutic Target in Human Epithelial Ovarian Cancer
- (2008) N. Yang et al. CANCER RESEARCH
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- (2008) Xi Chen et al. CELL RESEARCH
- Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin
- (2008) O. Kovalchuk et al. MOLECULAR CANCER THERAPEUTICS
- Circulating microRNAs as stable blood-based markers for cancer detection
- (2008) P. S. Mitchell et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More